| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11010-005-9043-0 |
| P698 | PubMed publication ID | 17001451 |
| P2093 | author name string | Binas B | |
| Erol E | |||
| P2860 | cites work | Selective cooperation between fatty acid binding proteins and peroxisome proliferator-activated receptors in regulating transcription | Q24540092 |
| Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting | Q24563197 | ||
| Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors alpha - and gamma-mediated gene expression via liver fatty acid binding protein: a signaling path to the nucleus | Q24612974 | ||
| A humble hexose monophosphate pathway metabolite regulates short- and long-term control of lipogenesis | Q27863765 | ||
| Uncoupling protein 3 as a mitochondrial fatty acid anion exporter | Q27887249 | ||
| A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders | Q28116120 | ||
| Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome | Q28205305 | ||
| Decreased Hepatic Triglyceride Accumulation and Altered Fatty Acid Uptake in Mice with Deletion of the Liver Fatty Acid-binding Protein Gene | Q28208142 | ||
| Effect of liver fatty acid binding protein (FABP) T94A missense mutation on plasma lipoprotein responsiveness to treatment with fenofibrate | Q28271786 | ||
| Targeting of nonexpressed genes in embryonic stem cells via homologous recombination | Q28506668 | ||
| CD36 in myocytes channels fatty acids to a lipase-accessible triglyceride pool that is related to cell lipid and insulin responsiveness | Q28578805 | ||
| Inactivation of fatty acid transport protein 1 prevents fat-induced insulin resistance in skeletal muscle | Q28586493 | ||
| Role of the fatty acid binding protein mal1 in obesity and insulin resistance | Q28587094 | ||
| Requirement for the heart-type fatty acid binding protein in cardiac fatty acid utilization | Q28593304 | ||
| The up-and-down beta-barrel proteins | Q30193828 | ||
| Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years. | Q33545914 | ||
| Cellular uptake and intracellular trafficking of long chain fatty acids | Q33700968 | ||
| The fatty acid transport function of fatty acid-binding proteins | Q33905931 | ||
| The mammalian fatty acid-binding protein multigene family: molecular and genetic insights into function | Q33944861 | ||
| Unravelling the significance of cellular fatty acid-binding proteins | Q34251142 | ||
| Fatty acid binding protein-2 gene variants and insulin resistance: gene and gene-environment interaction effects | Q34809926 | ||
| Insights into binding of fatty acids by fatty acid binding proteins | Q35024412 | ||
| Mechanisms of the free fatty acid-induced increase in hepatic glucose production | Q35099530 | ||
| Cytoplasmic fatty acid-binding protein facilitates fatty acid utilization by skeletal muscle | Q35178594 | ||
| Fatty acid interactions with proteins: what X-ray crystal and NMR solution structures tell us. | Q35683493 | ||
| Fatty acid-binding proteins--insights from genetic manipulations | Q35826917 | ||
| New concepts of cellular fatty acid uptake: role of fatty acid transport proteins and of caveolae. | Q35855938 | ||
| Unraveling the cellular mechanism of insulin resistance in humans: new insights from magnetic resonance spectroscopy | Q35860394 | ||
| Fatty acid binding proteins--the evolutionary crossroads of inflammatory and metabolic responses. | Q35873155 | ||
| Cytoplasmic codiffusion of fatty acids is not specific for fatty acid binding protein | Q36884816 | ||
| Inhibitory effects of long-chain acyl coenzyme a analogues on rat liver acetyl coenzyme a carboxylase | Q39257043 | ||
| Liver fatty acid-binding protein colocalizes with peroxisome proliferator activated receptor alpha and enhances ligand distribution to nuclei of living cells | Q40583952 | ||
| Variation of liver-type fatty acid binding protein content in the human hepatoma cell line HepG2 by peroxisome proliferators and antisense RNA affects the rate of fatty acid uptake | Q40969320 | ||
| Epithelial proliferation and differentiation in the mammary gland do not correlate with cFABP gene expression during early pregnancy | Q41672080 | ||
| Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. | Q42462295 | ||
| Increased lipolysis in transgenic animals overexpressing the epithelial fatty acid binding protein in adipose cells | Q42528212 | ||
| Analysis on the phenotype of E-FABP-gene knockout mice | Q42528637 | ||
| Evolution of the family of intracellular lipid binding proteins in vertebrates | Q42690586 | ||
| Giant membrane vesicles as a model to study cellular substrate uptake dissected from metabolism | Q44247041 | ||
| Decreased liver fatty acid binding capacity and altered liver lipid distribution in mice lacking the liver fatty acid-binding protein gene | Q44387480 | ||
| A Binding Protein for Fatty Acids in Cytosol of Intestinal Mucosa, Liver, Myocardium, and Other Tissues | Q44445325 | ||
| Long-chain fatty acid uptake by skeletal muscle is impaired in homozygous, but not heterozygous, heart-type-FABP null mice | Q44504787 | ||
| A null mutation in H-FABP only partially inhibits skeletal muscle fatty acid metabolism | Q44538182 | ||
| Liver fatty acid binding protein is required for high rates of hepatic fatty acid oxidation but not for the action of PPARalpha in fasting mice | Q44680979 | ||
| Liver fatty acid-binding protein gene ablation inhibits branched-chain fatty acid metabolism in cultured primary hepatocytes | Q44904775 | ||
| Heart fatty acid uptake is decreased in heart fatty acid-binding protein gene-ablated mice. | Q44934606 | ||
| Nonacute effects of H-FABP deficiency on skeletal muscle glucose uptake in vitro | Q44938041 | ||
| Discovery of inhibitors of human adipocyte fatty acid-binding protein, a potential type 2 diabetes target | Q45052017 | ||
| Heart-type fatty acid-binding protein reciprocally regulates glucose and fatty acid utilization during exercise | Q45083270 | ||
| Cardiomyocyte-restricted peroxisome proliferator-activated receptor-delta deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy | Q45099786 | ||
| Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein | Q45293298 | ||
| Ablation of the Liver Fatty Acid Binding Protein Gene Decreases Fatty Acyl CoA Binding Capacity and Alters Fatty Acyl CoA Pool Distribution in Mouse Liver | Q47597742 | ||
| Unsaturated fatty acids associated with glycogen may inhibit glucose-6 phosphatase in rat liver. | Q48732194 | ||
| Reduced hepatic fatty acid oxidation in fasting PPARalpha null mice is due to impaired mitochondrial hydroxymethylglutaryl-CoA synthase gene expression. | Q51555204 | ||
| Impaired long-chain fatty acid utilization by cardiac myocytes isolated from mice lacking the heart-type fatty acid binding protein gene. | Q52536097 | ||
| The intestinal fatty acid binding protein is not essential for dietary fat absorption in mice. | Q52541214 | ||
| The binding of fatty acids to cytoplasmic proteins: Binding to Z protein in liver and other tissues of the rat | Q70383581 | ||
| Specific inhibition of glucokinase by long chain acyl coenzymes A below the critical micelle concentration | Q70482981 | ||
| Fatty acid binding protein: stimulation of microsomal phosphatidic acid formation | Q73323647 | ||
| Long chain fatty acids inhibit and medium chain fatty acids activate mammalian cardiac hexokinase | Q73665974 | ||
| Constitutive regulation of cardiac fatty acid metabolism through peroxisome proliferator-activated receptor alpha associated with age-dependent cardiac toxicity | Q73762756 | ||
| Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice | Q74061464 | ||
| Glucose for the heart | Q77932890 | ||
| P433 | issue | 1-2 | |
| P304 | page(s) | 75-84 | |
| P577 | publication date | 2007-05-01 | |
| P1433 | published in | Molecular and Cellular Biochemistry | Q1573176 |
| P1476 | title | FABPs as determinants of myocellular and hepatic fuel metabolism | |
| P478 | volume | 299 |
| Q34126488 | A photocytes-associated fatty acid-binding protein from the light organ of adult Taiwanese firefly, Luciola cerata |
| Q37074304 | Adipocyte/macrophage fatty acid binding proteins in metabolic syndrome |
| Q28742345 | Altering pyrroloquinoline quinone nutritional status modulates mitochondrial, lipid, and energy metabolism in rats |
| Q51061389 | Association of IL-1β, IL-1Ra and FABP1 gene polymorphisms with the metabolic features of polycystic ovary syndrome. |
| Q36230931 | Effects of insulin resistance and hepatic lipid accumulation on hepatic mRNA expression levels of apoB, MTP and L-FABP in non-alcoholic fatty liver disease |
| Q57824312 | Emerging Roles of Vascular Endothelium in Metabolic Homeostasis |
| Q44582581 | Expression pattern of L-FABP gene in different tissues and its regulation of fat metabolism-related genes in duck |
| Q50641665 | Fatty Acid Binding Protein 3 Is Involved in n-3 and n-6 PUFA transport in mouse trophoblasts. |
| Q26749062 | Genetic Variation of Fatty Acid Oxidation and Obesity, A Literature Review |
| Q35925169 | Glp-1 analog, liraglutide, ameliorates hepatic steatosis and cardiac hypertrophy in C57BL/6J mice fed a Western diet |
| Q92632420 | Heart-Type Fatty Acid-Binding Protein (H-FABP) and its Role as a Biomarker in Heart Failure: What Do We Know So Far? |
| Q34452581 | Heart-type fatty acid-binding protein is essential for efficient brown adipose tissue fatty acid oxidation and cold tolerance. |
| Q42777939 | Hepatic transcriptome and proteome responses against diethyl maleate-induced glutathione depletion in the rat. |
| Q37719244 | Label-Free LC-MS Profiling of Skeletal Muscle Reveals Heart-Type Fatty Acid Binding Protein as a Candidate Biomarker of Aerobic Capacity. |
| Q34120131 | Liver fatty acid-binding protein and obesity |
| Q26753043 | Mitochondrial Molecular Pathophysiology of Nonalcoholic Fatty Liver Disease: A Proteomics Approach |
| Q37430604 | Molecular mechanism of recombinant liver fatty acid binding protein's antioxidant activity. |
| Q28817618 | Shugan Xiaozhi Decoction Attenuates Nonalcoholic Steatohepatitis by Enhancing PPARα and L-FABP Expressions in High-Fat-Fed Rats |
| Q38887137 | The Effects of Acute and Chronic Exercise on Skeletal Muscle Proteome. |
| Q30156061 | Tissue-specific functions in the fatty acid-binding protein family |
Search more.